Truist Securities Maintains Buy on Ardent Health, Lowers Price Target to $12

Benzinga Newsdesk www.benzinga.com Neutral 50.8%

Neg 0% Neu 50.8% Pos 0%

Truist Securities analyst David Macdonald maintains Ardent Health (NYSE:ARDT) with a Buy and lowers the price target from $13 to $12.